Hangzhou Tigermed: Share capital stable through October 2025

Hangzhou Tigermed Consulting Co., Ltd. announced that its total authorised and registered share capital remained at RMB861,026,050 as of October 31, 2025. This figure comprises RMB737,901,250 for A shares and RMB123,124,800 for H shares, with no increase or decrease during the month.

The company's issued share capital also held steady, with 732,017,470 A shares (excluding treasury shares) and 5,883,780 treasury A shares, totaling 737,901,250 A shares. For H shares, the number of issued shares (excluding treasury shares) remained at 123,124,800, with no treasury H shares, leading to a total of 123,124,800 H shares.

A total of 5,883,780 repurchased A shares are held as treasury shares as at October 31, 2025. This follows several repurchase activities between May 2024 and February 2025, and the cancellation of 3,922,520 treasury shares on May 29, 2025.